Actively Recruiting
Multi-Session 40 Hz Visual Stimulation to Improve Brain Activity and Symptoms in Schizophrenia
Led by Technical University of Munich · Updated on 2025-04-02
20
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the use of 40 Hz visual stimulation as an add-on method to help improve negative symptoms, including cognitive difficulties, in people with schizophrenia or schizoaffective disorder. The study is a pilot trial comparing a group receiving visual stimulation with a group receiving their usual treatment. The goal is to assess whether this non-invasive brain stimulation method can influence brain activity patterns linked to symptoms and improve mood and cognition. Participants in the experimental group will undergo one hour of 40 Hz visual stimulation each day for five consecutive days using a customized sleep mask with red LEDs flickering at 40 Hz. They will lie down with their eyes closed and be encouraged to fall asleep during the stimulation. The control group will continue their usual treatment without additional intervention. The study includes pre- and post-assessments conducted before the first and after the last stimulation session. EEG brain activity will be recorded during the first and last stimulation sessions. Throughout the study, participants will complete mood and cognitive tests, and trained physicians will assess psychiatric symptoms. The visual stimulation sessions will be monitored for any side effects by asking participants about undesired effects after each session. EEG data will be analyzed to measure brain responses to the stimulation. The total study duration includes multiple assessment sessions before and after the stimulation week, providing detailed information on brain and symptom changes related to the intervention.
CONDITIONS
Brief Title
40 Hz Visual Stimulation as an Intervention in Schizophrenia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Medical diagnosis of schizophrenia (F20) or schizoaffective disorder (F25)
You will not qualify if you...
- Age less than 18 years
- Any history of seizures
- Acute suicidality assessed with the Columbia-Suicide Severity Rating Scale (C-SSRS)
- Any other relevant axis 1 disorder
- Red-green colour blindness or current ocular disease
- Alcohol, cannabis, or illicit drug addiction within the last 3 months
Research Team
U
Ulrike Vogelmann, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here